Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
Victor Abler, Cecilia Brain, Clive Ballard, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8

Showing 8 citing articles:

Comprehensive analysis of adverse events associated with pimavanserin using the FAERS database
Jun Gu, Yucai Qu, Yüan Shen, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 742-748
Closed Access | Times Cited: 8
Parkinson’s disease therapy: what lies ahead?
Andreas Wolff, Nicolas U Schumacher, Dominik Pürner, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 793-820
Open Access | Times Cited: 15
Post-marketing safety of pimavanserin: a real-world pharmacovigilance study based on the FDA adverse event reporting system (FAERS)
Dong Liu, Xueni Zhang, Haiyan Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Sedation and sleep safety of pimavanserin for Parkinsons’s disease Psychosis: Review and exploratory analysis of clinical study data
Ana Berrio, Lambros Chrones, Victor Abler, et al.
Clinical Parkinsonism & Related Disorders (2025), pp. 100342-100342
Open Access
Treatment of Parkinson’s Disease Psychosis—A Systematic Review and Multi-Methods Approach
Olaf Rose, S. J. Huber, Eugen Trinka, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2317-2317
Open Access | Times Cited: 1
Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
Beatrice Heim, Marina Peball, Florian Krismer, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1303-1312
Open Access | Times Cited: 3
Implications of Pimavanserin in Patients with Dementia-related Psychosis: A Systematic Review
Heet N Desai, Mithum Senaratne, Shivling S Swami, et al.
Journal of Medical Sciences (2024)
Open Access
Clinical Pipelines for Alzheimer’s Disease Psychosis and Agitation
Takuya Oguma, Kohei Jino
Chemical and Pharmaceutical Bulletin (2024) Vol. 72, Iss. 7, pp. 610-617
Open Access
Psychiatric Disorders and Cognitive Fluctuations in Parkinson’s Disease: Changing Approaches in the First Decades of the 21st Century
Marco Onofrj, Matteo Alessandro De Rosa, Mirella Russo, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1233-1233
Open Access
Page 1

Scroll to top